NDC 43742-0208

Carcinosin

Carcinosin

Carcinosin is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Human Breast Tumor Cell.

• Product ID: 43742-0208_d6814660-ae4e-4885-99bb-b929a93b7a5e
• NDC: 43742-0208
• Product Type: Human Otc Drug
• Proprietary Name: Carcinosin
• Generic Name: Carcinosin
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2012-10-08
• Marketing End Date: 2020-09-02
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Deseret Biologicals, Inc.
• Substance Name: HUMAN BREAST TUMOR CELL
• Active Ingredient Strength: 30 [hp_C]/mL
• NDC Exclude Flag: N

Packaging

NDC 43742-0208-1

30 mL in 1 BOTTLE, DROPPER (43742-0208-1)

• Marketing Start Date: 2012-10-08
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 43742-0208-1 [43742020801]

Carcinosin LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2012-10-08
• Marketing End Date: 2020-09-02

Drug Details

Active Ingredients

Ingredient	Strength
HUMAN BREAST TUMOR CELL	30 [hp_C]/mL

OpenFDA Data

• SPL SET ID: 0d1896ac-d3ab-4487-a92d-ae0ae1ec97e4
• Manufacturer:
  • Deseret Biologicals, Inc.
• UNII:
  • C62OO7VD9K

NDC Crossover Matching brand name "Carcinosin" or generic name "Carcinosin"

NDC	Brand Name	Generic Name
43742-0208	Carcinosin	Carcinosin
43742-0676	Carcinosin	Carcinosin
44911-0191	CARCINOSIN CORD	Carcinosin
44911-0530	CARCINOSIN CORD	Carcinosin